Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Gut ; 44(1): 55-64, 1999 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-9862826

RESUMO

BACKGROUND: The pathophysiological mechanisms in non-ulcer dyspepsia are incompletely understood. AIMS: To compare gastric motor and sensory functions in Helicobacter pylori positive or negative patients with non-ulcer dyspepsia. PATIENTS: Seventeen patients with non-ulcer dyspepsia and 16 asymptomatic controls. METHODS: The following were evaluated: gastrointestinal symptoms; gastric emptying and orocaecal transit of solids; abdominal vagal function; gastric compliance; fasting and postprandial gastric tone and phasic contractions; symptoms during ingestion of cold water and during the distension of an intragastric bag; and somatic sensitivity and personality profile (Minnesota Multiphasic Personality Inventory, MMPI). RESULTS: Gastric accommodation was reduced in H pylori negative dyspeptics relative to controls; the degree of accommodation was unrelated to H pylori status in dyspeptics. Increased postprandial gastric sensation was more frequent among H pylori positive patients (4/5 H pylori positive versus 4/12 H pylori negative patients). Intragastric meal distribution and orocaecal transit were normal; gastric emptying at four hours was abnormal in 4/17 patients. Vagal dysfunction was rare. Eight of 17 patients had somatisation or depression on MMPI. CONCLUSION: Impaired gastric accommodation is frequent in non-ulcer dyspepsia and seems to be unrelated to vagal efferent dysfunction. H pylori infection does not seem to influence gastric accommodation, but is associated with heightened sensitivity in dyspeptics. Therapeutic approaches that restore normal postprandial accommodation and gastric sensitivity should be tested in non-ulcer dyspepsia.


Assuntos
Dispepsia/fisiopatologia , Infecções por Helicobacter/fisiopatologia , Helicobacter pylori , Estômago/fisiopatologia , Nervo Vago/fisiopatologia , Adulto , Complacência (Medida de Distensibilidade) , Dispepsia/microbiologia , Feminino , Esvaziamento Gástrico/fisiologia , Trânsito Gastrointestinal/fisiologia , Infecções por Helicobacter/complicações , Humanos , Masculino , Pessoa de Meia-Idade , Período Pós-Prandial , Sensação
2.
Gut ; 42(5): 628-34, 1998 May.
Artigo em Inglês | MEDLINE | ID: mdl-9659155

RESUMO

BACKGROUND: Carcinoid diarrhoea is associated with rapid small bowel and proximal colonic transit. Intravenous administration of a serotonin type 3 receptor (5HT3) antagonist restores postprandial colonic tone towards normal in carcinoid patients. AIMS: To evaluate the medium-term effects of an oral 5HT3 antagonist, alosetron, on symptoms, stool fat, and transit in patients with carcinoid diarrhoea. METHODS: In 27 patients with carcinoid diarrhoea, symptoms were recorded daily and gastrointestinal transit was measured by scintigraphy in a three dose (0.1, 0.5, 2.0 mg, twice daily), randomised (1:1:1), parallel group, four week study. Placebo was given during the first week. Loperamide (2 mg capsules) was used as rescue medication. RESULTS: There were numerical improvements in median diarrhoea score, stool weight, loperamide use, and overall colonic transit at four hours, but no overall significant drug effect was shown. Alosetron reduced the proximal colon emptying rate (p < 0.05 in 20 evaluable comparisons), but did not significantly alter small bowel transit. CONCLUSIONS: Alosetron retardation of proximal colonic emptying in patients with carcinoid diarrhoea confirms the potential role of a 5HT3 mechanism in this disorder. Doses of alosetron higher than 2.0 mg twice daily will be required for symptomatic benefit in carcinoid diarrhoea.


Assuntos
Carbolinas/administração & dosagem , Tumor Carcinoide/secundário , Diarreia/tratamento farmacológico , Neoplasias Intestinais/secundário , Antagonistas da Serotonina/administração & dosagem , Adulto , Idoso , Idoso de 80 Anos ou mais , Carbolinas/uso terapêutico , Tumor Carcinoide/complicações , Tumor Carcinoide/fisiopatologia , Colo/fisiopatologia , Diarreia/etiologia , Diarreia/fisiopatologia , Método Duplo-Cego , Esquema de Medicação , Feminino , Motilidade Gastrointestinal/efeitos dos fármacos , Trânsito Gastrointestinal/efeitos dos fármacos , Humanos , Neoplasias Intestinais/complicações , Neoplasias Intestinais/fisiopatologia , Masculino , Pessoa de Meia-Idade , Análise de Regressão , Antagonistas da Serotonina/uso terapêutico , Estatísticas não Paramétricas
3.
Dig Dis Sci ; 43(2): 258-64, 1998 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-9512116

RESUMO

The effect of H. pylori infection on gastric motility and sensation is unclear. Our hypothesis is that H. pylori infection increases gastric sensation and reduces gastric accommodation and emptying. In eight H. pylori-positive and eight H. pylori-negative asymptomatic subjects, infection was proven by antral histology or culture. We evaluated: (1) gastric emptying of solids, (2) proximal gastric compliance, (3) fasting and postprandial proximal gastric tone and phasic contractions, (4) gastric sensation during balloon inflations or ingestion of cold water, and (5) abdominal vagal function. H. pylori infection was associated with lower gastric accommodation (median 75% postprandial increase in barostat balloon volume compared to fasting) when compared to the accommodation in uninfected volunteers (median 211% change from fasting). One H. pylori-positive subject had an abnormal abdominal vagal function test and her gastric accommodation response was reduced. Other motor and sensory functions in the two groups were similar. In asymptomatic volunteers, H. pylori infection and gastritis result in reduced accommodation (diastolic dysfunction) but no change in overall sensation or motor functions of the stomach.


Assuntos
Motilidade Gastrointestinal , Infecções por Helicobacter/fisiopatologia , Helicobacter pylori , Sensação , Estômago/fisiologia , Adulto , Feminino , Esvaziamento Gástrico/fisiologia , Gastrite/fisiopatologia , Humanos , Masculino , Pessoa de Meia-Idade
4.
Am J Gastroenterol ; 92(12): 2250-6, 1997 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-9399764

RESUMO

OBJECTIVES: Previous studies showed increased plasma motilin and substance P concentrations and accelerated motor function in the small bowel and colon in patients with carcinoid diarrhea. Octreotide is beneficial in patients with carcinoid syndrome. Our hypothesis was that octreotide inhibits accelerated motility and gut neuropeptides in carcinoid syndrome. METHODS: In 12 patients with metastatic carcinoid syndrome, we investigated the effect of octreotide 50 microg s.c. t.i.d (n = 6) or placebo (n = 6) on postprandial symptoms, GI transit, colonic motility, and circulating levels of selected circulating peptides and amines. RESULTS: Octreotide reduced postprandial flushing (p = 0.03) but not pain. Octreotide significantly retarded overall colonic transit and proximal colonic emptying (p < 0.05); it tended to prolong small bowel transit time (p = 0.13) and to reduce postprandial colonic tone (p = 0.08) compared with placebo. Octreotide also reduced circulating levels of peptide YY, neurotensin, vasoactive intestinal polypeptide, and substance P but had no effect on plasma motilin, neuropeptide Y, calcitonin gene-related peptide, or histamine after meal ingestion. CONCLUSION: Octreotide ameliorates gut motor dysfunctions that characterize carcinoid diarrhea; the potential role of specific antagonism of serotonin, substance P, and vasoactive intestinal polypeptide alone or in combination with agents that inhibit their release in carcinoid diarrhea deserves further study.


Assuntos
Antineoplásicos Hormonais/uso terapêutico , Doenças do Colo/tratamento farmacológico , Rubor/tratamento farmacológico , Fármacos Gastrointestinais/uso terapêutico , Motilidade Gastrointestinal/efeitos dos fármacos , Síndrome do Carcinoide Maligno/tratamento farmacológico , Octreotida/uso terapêutico , Idoso , Antineoplásicos Hormonais/administração & dosagem , Peptídeo Relacionado com Gene de Calcitonina/sangue , Colo/efeitos dos fármacos , Diarreia/tratamento farmacológico , Digestão/efeitos dos fármacos , Método Duplo-Cego , Feminino , Fármacos Gastrointestinais/administração & dosagem , Trânsito Gastrointestinal/efeitos dos fármacos , Histamina/sangue , Humanos , Intestino Delgado/efeitos dos fármacos , Masculino , Síndrome do Carcinoide Maligno/sangue , Pessoa de Meia-Idade , Motilina/sangue , Neuropeptídeo Y/sangue , Neuropeptídeos/antagonistas & inibidores , Neurotensina/antagonistas & inibidores , Neurotensina/sangue , Octreotida/administração & dosagem , Peptídeo YY/antagonistas & inibidores , Peptídeo YY/sangue , Placebos , Antagonistas da Serotonina/sangue , Substância P/antagonistas & inibidores , Substância P/sangue , Peptídeo Intestinal Vasoativo/antagonistas & inibidores , Peptídeo Intestinal Vasoativo/sangue
5.
Gastroenterol Clin North Am ; 25(1): 247-58, 1996 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-8682576

RESUMO

This article reviews the basic anatomy and physiology of visceral afferent function and its application to a clearer understanding of visceral pain and symptoms in patients with functional gastrointestinal disorders. Recent investigations have focused on the potential role of visceral tone, different afferent (A delta and C) fibers, dorsal column neurons, and supraspinal modulation in the elicitation of visceral perception of noxious and nonnoxious stimuli arising in the gut. Greater understanding of these pathomechansims and their pharmacologic manipulation offers an opportunity for future therapeutic strategies for these disorders.


Assuntos
Fenômenos Fisiológicos do Sistema Digestório , Gastroenteropatias/fisiopatologia , Sensação/fisiologia , Vias Aferentes/fisiologia , Humanos , Dor/fisiopatologia
6.
Gastroenterology ; 110(2): 405-10, 1996 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-8566586

RESUMO

BACKGROUND & AIMS: Fat and complex carbohydrates in the distal bowel activate "brakes" inhibiting upper gut motility. The hypothesis of this study was that rapid transit carcinoid diarrhea in association with steatorrhea results in impairment of gastric emptying. METHODS: Fifteen patients with carcinoid diarrhea without prior gastrointestinal resection or whose small bowel resection was limited to < 100 cm of ileum were studied. Gastrointestinal transit was measured scintigraphically with a standardized meal. Percentage of ingested fat excretion was calculated. RESULTS: Mean length of small bowel resected was 33 cm, and mean 24-hour urine 5-hydroxyindoleacetic acid was 120 mg. Fourteen patients had increased daily stool weights, and 10 had increased stool fat excretion (mean, 13%). Transit was accelerated in the small bowel in 14 and in the colon in all patients. The lag time for gastric emptying was prolonged in 2 patients who had no previous resection. Gastric emptying rate was accelerated in 5, normal in 7, and delayed in 3 patients. CONCLUSIONS: Ileal and colonic brakes do not seem to delay gastric emptying in patients with carcinoid diarrhea associated with rapid transit and mild to moderate steatorrhea.


Assuntos
Diarreia/fisiopatologia , Gorduras na Dieta/farmacocinética , Trânsito Gastrointestinal , Absorção Intestinal , Síndrome do Carcinoide Maligno/fisiopatologia , Idoso , Idoso de 80 Anos ou mais , Doença Celíaca/etiologia , Colo/fisiopatologia , Diarreia/etiologia , Diarreia/metabolismo , Feminino , Esvaziamento Gástrico , Humanos , Ácido Hidroxi-Indolacético/urina , Intestino Delgado/fisiopatologia , Masculino , Síndrome do Carcinoide Maligno/complicações , Síndrome do Carcinoide Maligno/metabolismo , Pessoa de Meia-Idade
8.
Gastroenterology ; 109(3): 755-65, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-7657103

RESUMO

BACKGROUND & AIMS: The roles of hyperglycemia in diabetic gastroparesis and gastric delivery in postprandial hyperglycemia of diabetic patients are unclear. The aims of this study were to assess gastric emptying and its relation to postprandial glucose metabolism in patients with asymptomatic non-insulin-dependent diabetes mellitus (NIDDM) and no autonomic neuropathy and to identify motor mechanisms responsible for any accelerated gastric emptying. METHODS: Autonomic function, gastric emptying, postprandial glucose metabolism, and hormone levels (glucagon, insulin, cholecystokinin, glucose-dependent insulinotropic polypeptide, neurotensin, and peptide YY) were assessed in healthy volunteers and patients with NIDDM. In a second study, gastric tone and motility were measured in patients with accelerated gastric emptying and in controls. RESULTS: Gastric emptying of solids did not differ in the two groups, but liquids emptied faster in patients with NIDDM (P < 0.02). The rate of entry of ingested glucose into the systemic circulation was similar, but higher postprandial glucagon and lower insulin concentrations led to greater (P < 0.01) postprandial hepatic glucose release. Levels of other enteropeptides, gastric accommodation, and antral motility were similar, but patients with NIDDM had greater proximal gastric phasic contractions than controls (P < 0.05). CONCLUSIONS: Excessive hepatic glucose release, not rapid entry of ingested glucose, is the primary cause of postprandial hyperglycemia in patients with NIDDM. Accelerated gastric emptying in patients with nonneuropathic NIDDM is associated with increased proximal stomach phasic contractions.


Assuntos
Diabetes Mellitus Tipo 2/fisiopatologia , Esvaziamento Gástrico , Hiperglicemia/fisiopatologia , Sistema Nervoso Autônomo/fisiopatologia , Diabetes Mellitus Tipo 2/complicações , Diabetes Mellitus Tipo 2/metabolismo , Ingestão de Alimentos , Feminino , Motilidade Gastrointestinal , Glucagon/sangue , Glucose/metabolismo , Humanos , Hiperglicemia/etiologia , Hiperglicemia/metabolismo , Insulina/sangue , Fígado/metabolismo , Masculino , Pessoa de Meia-Idade , Contração Muscular , Estômago/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA